- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on May 21, 2024)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| May 21, 2024 | T-1039-23 | CMC | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 h |
| May 22, 2024 | T-1040-23 | M | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 1 d |
| May 22, 2024 | T-311-20 | CMC | Visionwall International, Inc. V. Litezone Technologies Inc. Et Al (Trade Mark) | Edmonton | 30 m |
| May 22, 2024 | T-923-24 | CMC | Janssen Inc. And Mitsubishi Tanabe Pharma Corporation V. Apotex Inc. (Patent) | Toronto | 30 m |
| May 24, 2024 | T-724-21 | CMC | Planet Fitness Inc. V. Planet Fitness Franchising Llc, Aka Pfip, Llc (Trade Mark) | Edmonton | 30 m |
| May 27, 2024 | T-1563-22 | T | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 2 d |
| May 27, 2024 | T-44-24 | JR | Red Maple Manufacturing Inc. V. Red Maple Bio Inc. (Trade Mark - JR) | Ottawa | 1 h |
| May 27, 2024 | T-1094-23 | CMC | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Ottawa | 1 h |
| May 27, 2024 | T-1095-23 | CMC | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Ottawa | 1 h |
| May 27, 2024 | T-92-24 | CMC | Bayer Inc. Et Al V. Celltrion, Inc. Et Al. (Patent) | Ottawa | 1 h |
| May 27, 2024 | T-93-24 | CMC | Bayer Inc. Et Al. V. Celltrion, Inc. Et Al. (Patent) | Ottawa | 1 h |
| May 27, 2024 | T-94-24 | CMC | Bayer Inc. Et Al. V. Celltrion, Inc. Et Al. (Patent) | Ottawa | 1 h |
| May 27, 2024 | T-96-24 | CMC | Bayer Inc. Et Al.v. Celltrion, Inc. Et Al. (Patent) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| May 27, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 2 d |
| Jun 17, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | Toronto | 10 d |
| Jul 11, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | Vancouver | 1 d |
| Jul 15, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Jul 15, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 12, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 19, 2024 | T-233-23 | Poseidon Llc. V. Canada (the Commissioner Of Patents) (unknown) | Toronto | 2 d |
| Aug 28, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 3 d |
| Aug 28, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 3 d |
| Aug 29, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Aug 29, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Sep 9, 2024 | T-435-22 | Australian Mud Company Pty Ltd Et Al. V. Boart Longyear Group Inc. Et Al. (Patent) | Toronto | 10 d |
| Sep 9, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 8 d |
| Sep 16, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 10 d |
| Sep 16, 2024 | T-86-23 | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Toronto | 10 d |
| Sep 19, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 7 d |
| Sep 25, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 2 d |
| Oct 2, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 2 d |
| Oct 15, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 1 d |
| Oct 21, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. Et Al. (Copyright) | To be determined (TrialJA) | 10 d |
| Oct 28, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Toronto | 16 d |
| Nov 12, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 10 d |
| Nov 25, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Ottawa | 3 d |
| Dec 2, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | To be determined (TrialJA) | 9 d |
| Dec 2, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 2 d |
| Dec 18, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | To be determined (TrialJA) | 2 d |
| Jan 13, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 7 d |
| Feb 3, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 8 d |
| Feb 10, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 20, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 1 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 10, 2025 | T-449-20 | Basf Llc Et Al. V. Agracity Crop & Nutrition Ltd. Et Al. (Trade Mark) | Toronto | 6 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 15 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| May 12, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 19 d |
| May 12, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 19 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 26, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 10 d |
| May 26, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 3 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 9, 2025 | T-1430-23 | Otsuka Pharmaceutical Co., Ltd V. Teva Canada Limited (Patent) | Toronto | 10 d |
| Jun 11, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 2 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Jun 23, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 14 d |
| Jun 23, 2025 | T-2013-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co. Ltd. (Patent) | Toronto | 14 d |
| Jul 16, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 2 d |
| Jul 16, 2025 | T-2013-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co. Ltd. (Patent) | Toronto | 2 d |
| Jul 22, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Jul 22, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Aug 11, 2025 | T-2251-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent) | Toronto | 15 d |
| Aug 11, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 8 d |
| Aug 25, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-2251-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Toronto | 12 d |
| Sep 2, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Sep 15, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Sep 22, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 22, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 25, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Ottawa | 2 d |
| Oct 6, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 6, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 27, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 2 d |
| Nov 12, 2025 | T-1584-23 | Amgen Canada Inc. V. Alexion Pharmaceuticals, Inc. (Patent) | Toronto | 28 d |
| Nov 12, 2025 | T-1779-23 | Samsung Bioepis Co., Ltd V. Alexion Pharmaceuticals, Inc. (Copyright) | Toronto | 28 d |
| Nov 12, 2025 | T-296-24 | Bayer Inc. Et Al. V. Natco Pharma (canada) Inc. Et Al. (Patent) | Ottawa | 11 d |
| Nov 17, 2025 | T-2148-23 | Outsuka Pharmaceutical Co. Ltd. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 24, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 8 d |
| Nov 27, 2025 | T-297-23 | Dermaspark Products Inc. Et Al. V. Natural Oasis Day Spa Ltd. Et Al (Trade Mark) | Ottawa | 12 d |
| Dec 1, 2025 | T-675-24 | Pfizer Canada Ulc Et Al. V. Glenmark Pharmaceuticals Canada Inc. Et Al. (Patent) | Ottawa | 10 d |
| Dec 8, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 2 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| May 27, 2024 | T-44-24 | Red Maple Manufacturing Inc. V. Red Maple Bio Inc. | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 1 h |
| Jun 6, 2024 | T-1895-23 | Smart And Biggar Llp V. Canadian Tire Corporation, Ltd | Trade Mark Infringement | Toronto | 1 d |
| Jun 10, 2024 | T-654-22 | Giuseppe De Luca V. Geox S.p.a. | Trade Mark Expungement | Montréal | 3 h |
| Jun 17, 2024 | T-1369-23 | Emd Serono Et Al V. The Minister Of Health - Cladribine* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jun 18, 2024 | T-2144-23 | T. Rowe Price Group, Inc. V. Glidepath Technologies Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Jun 18, 2024 | T-2728-23 | Bayer Inc V. Amgen Canada Inc. Et Al. - Aflibercept* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jul 9, 2024 | T-901-22 | C-tow Marine Assistance Ltd. V. Sea Tow Services International, Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1.3 d |
| Jul 15, 2024 | T-1105-22 | Monster Energy Company V. Iicombined Co. Ltd. | Trade Mark Opposition | Ottawa | 1 d |
| Jul 23, 2024 | T-1706-23 | 2k4 Inc. O/a Indican Pictures V. Indiecan Entertainment Inc. | Trade Mark - Passing Off | Ottawa | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| May 13, 2024 | A-248-22 | Agracity Crop & Nutrition Ltd. V. Upl Na Inc. Et Al | Appeal (S.27 - Interloc.) - Others [from T-604-19 - Patent Infringement] | Toronto |
| May 13, 2024 | A-37-23 | Agracity Crop Et Al. V. Upl Na Inc. Et Al. | Appeal (S.27 - Final) - Others [from T-604-19 - Patent Infringement] | Toronto |
| May 16, 2024 | A-152-23 | Bell Canada Et Al V. Millennium Funding, Inc., Et Al | Appeal (S.27 - Final) - Copyright Act [from T-1062-21 - Copyright Infringement [Actions]] | Toronto |
| May 28, 2024 | A-27-24 | Biogen Inc. Et Al V. Novartis Ag Et Al | Appeal (S.27 - Final) - Trade-marks Act [from T-1664-22 - Trade Mark Infringement] | Toronto |
| May 28, 2024 | A-26-24 | Samsung Bioepis Co., Ltd V. Novartis Ag Et Al. | Appeal (S.27 - Interloc.) - Trade-marks Act [from T-1664-22 - Trade Mark Infringement] | Toronto |
| Jun 4, 2024 | A-105-22 | Munchkin, Inc Et Al. V. Angelcare Canada Inc. Et Al. | Appeal (S.27 - Final) - Patent Act [from T-151-16 - Patent Infringement] | Ottawa |
| Jun 4, 2024 | A-106-22 | Angelcare Canada Inc. Et Al V. Munchkin, Inc. Et Al | Appeal (S.27 - Final) - Patent Act [from T-151-16 - Patent Infringement] | Ottawa |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.